Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]Chikao Morimoto, Kei OhnumaNihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Antibody therapy for malignant mesothelioma: humanized anti-cD26 mAb therapy]Chikao Morimoto, Kei OhnumaNihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Targeted therapy by monoclonal antibodies]Kei Ohnuma, Chikao MorimotoTrends in Immunology|May 6, 2008
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell functionKei Ohnuma, Nam H Dang, Chikao MorimotoModern Rheumatology|October 5, 2018
Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapyKei Ohnuma, Ryo Hatano, Nam H Dang, et al.Advances in Clinical Chemistry|March 17, 2011
Dipeptidyl peptidase in autoimmune pathophysiologyKei Ohnuma, Osamu Hosono, Nam H Dang, et al.Modern Rheumatology|January 7, 2014
CD26: a key molecule in immune regulation and autoimmune diseasesOsamu Hosono, Kei Ohnuma, Nam H Dang, et al.Cureus|March 29, 2021
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological FunctionsKelsey Pan, Kei Ohnuma, Chikao Morimoto, et al.Immunology|November 2, 2012
CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine productionRyo Hatano, Kei Ohnuma, Junpei Yamamoto, et al.Biochemical and Biophysical Research Communications|March 26, 2008
SSA/Ro52 autoantigen interacts with Dcp2 to enhance its decapping activityTadanori Yamochi, Kei Ohnuma, Osamu Hosono, et al.Pageof 15